Home
Live Updates
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine : comparemela.com
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine
- Stanford Medicine, a center with a long tradition of leadership in pioneering gynecological research and innovation, is the second academic center to participate in the FemBloc pivotal trial since...
Related Keywords
United States ,
Stanford ,
California ,
Palo Alto ,
Canada ,
Chuck Padala ,
Erica Cahill ,
Femasy Femaseed ,
Kathy Lee Sepsick ,
Paul Blumenthal ,
Femasy Fembloc ,
Nasdaq ,
Linkedin ,
Lifesci Advisors ,
Facebook ,
Drug Administration ,
Femasys Inc ,
Stanford Medicine Obstetrics ,
Stanford Medicine ,
Fembloc Intratubal Occlusion ,
Birth Control ,
United States Food ,
Doctors Blumenthal ,
Intratubal Insemination ,
Looking Statements ,
Annual Report ,
Sci Advisors ,
Markets ,
comparemela.com © 2020. All Rights Reserved.